Your Cart ( 1 Item )

• Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque Psoriasis
  August 2024 | Volume 23 | Issue 8 | Original Article | 612 | Copyright © August 2024
  Jayme Heim MSN FNP-BC^a, J. Gabriel Vasquez MD^a, Tina Bhutani MD MAS FAAD^b, John Koo MD^b, Jacob Mathew PharmD MBA^c, Ranga Gogineni PhD^c, Thomas Ferro MD^c, Neal Bhatia MD FAAD^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs